PDAC

A common mutation in the KRAS gene is associated with OS in PDAC – Weill Cornell Medicine

Weill Cornell Medicine shared a post on X:

“A common mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma (PDAC) compared with other variants, according to new study led by Dr. Rohit Chandwani of Weill Cornell Medicine Surgery.

Full story.”

Source: Weill Cornell Medicine/X

More posts featuring Weill Cornell Medicine.

cancer OncoDaily Oncology pancreatic ductal adenocarcinoma PDAC Rohit Chandwani Weill Cornell Medicine Weill Cornell Medicine Surgery